Abstract

Objective To observe and compare the efficacy of PropessTM with that of oxytocin for cervical ripening and labor induction in pregnancies. Methods 80 pregnant women who gave birth during the period of January 2010 to October 2010 in our hospital were selected as the subjects. They were all full-term pregnant with induction indications and normal ultrasound images but no pregnancy complications. They were randomly assigned to receive PropessTM vaginal insert ( 40 women,study group )or low-dose oxytocin ( 40 women, control group ) for cervical ripening and induction. The Bishop scores and birth outcomes were compared between the two groups when the trial was finished. Results The PropessTM for cervical ripening rate was 95%,low-dose oxytocin was 42.5%. 28 cases of 40 in the PropessTM were vaginal delivery, vaginal delivery rate was 70%, however, the oxytocin group 17 cases of 40 subjects were vaginal delivery,the vaginal delivery rate was 42.5%. Conclusions Compared with low-dose oxytocin the PropessTM can dramaticaly promote cervical ripening in full-term singleton pregnant women,increase rates of vaginal delivery and it is better than low-dose oxytocin in the planned delivery, it's worthy of clinical use. Key words: The PropessTM Oxytocin; Labor induction

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call